Dr. Tobias Schmelzle, Novartis Institutes for Biomedical Research

Identifying and validating novel cancer targets

Start Date 05.12.2018 - 17:15
Event End 05.12.2018 - 18:00
Location ETH Zürich, Hönggerberg

Identifying and validating novel cancer targets